FBXL16 is a novel E2F1-regulated gene commonly upregulated in p16INK4A- and p14ARF-silenced HeLa cells

Kazuyuki Sato1, Yusuke Kusama, Moe Tategu

  • 1Department of Life Sciences, Faculty of Agriculture, Meiji University, Tama-ku, Kawasaki, Kanagawa 214-8571, Japan.

Insights

The cyclin-dependent kinase inhibitor 2A (CDKN2A) gene locus produces tumor suppressors p16INK4A and p14ARF. Loss of these proteins commonly upregulates FBXL16, impacting cell proliferation.

Area of Science:

  • Molecular biology
  • Cell cycle regulation
  • Oncology

Background:

  • The cyclin-dependent kinase inhibitor 2A (CDKN2A) locus encodes tumor suppressors p16INK4A and p14ARF.
  • These proteins are critical regulators of cell cycle control and tumor suppression.
  • The molecular consequences of acute CDKN2A loss and the interplay between p16INK4A/pRb/E2F1 and p14ARF/p53 pathways are not fully understood.

Purpose of the Study:

  • To investigate the molecular events following the functional loss of p16INK4A and p14ARF.
  • To identify novel factors involved in the p16INK4A/pRb/E2F1 and p14ARF/p53 regulatory pathways.
  • To elucidate the interdependence of these two critical cell fate pathways.

Main Methods:

  • RNA interference (RNAi) was used to specifically decrease p16INK4A or p14ARF expression in HeLa cells.
  • DNA microarray analysis identified commonly regulated genes in knockdown cells.
  • RT-PCR validated the upregulation of target genes, specifically FBXL16.
  • Promoter analysis investigated the regulatory mechanisms of FBXL16.

Main Results:

  • Commonly regulated genes were identified in both p16INK4A and p14ARF knockdown cells.
  • FBXL16 (F-box and leucine-rich repeat protein 16) expression was reproducibly upregulated in both knockdown conditions.
  • The promoter of FBXL16 was found to be upregulated by activator E2Fs.
  • Knockdown of FBXL16 using RNAi led to increased cell proliferation rates in HeLa cells.

Conclusions:

  • The study reveals a molecular interdependence between the p16INK4A/pRb/E2F1 and p14ARF/p53 pathways.
  • FBXL16 is a novel gene commonly regulated by the loss of p16INK4A and p14ARF.
  • FBXL16 plays a role in regulating cell proliferation, suggesting its involvement in tumorigenesis.